Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chimeric cyclodepsipeptides as mimetics for the anthelmintic PF1022A.

Hubert Dyker1, Achim Harder, Jürgen Scherkenbeck

  • 1Bayer Healthcare Pharma, 42096 Wuppertal, Germany.

Bioorganic & Medicinal Chemistry Letters
|November 18, 2004
PubMed
Summary

Researchers modified the anthelmintic PF1022A by replacing backbone units with beta-turn mimetics. This resulted in novel analogues with enhanced anthelmintic activity, suggesting a symmetric conformation is key.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Towards selective peptide deformylase inhibitors: A mass spectrometry-based evaluation of in cellulo activity of actinonin and bromoindole derivatives.

European journal of medicinal chemistry·2026
Same author

Monophthalates of betulinic acid and related pentacyclic triterpenes inhibit efficiently the SOS-mediated nucleotide exchange and impact PI3K/AKT signaling in oncogenic K-RAS4B proteins.

RSC advances·2025
Same author

Toward More Selective Antibiotic Inhibitors: A Structural View of the Complexed Binding Pocket of <i>E. coli</i> Peptide Deformylase.

Journal of medicinal chemistry·2024
Same author

Structural Insights into Antibacterial Payload Release from Gold Nanoparticles Bound to E. coli Peptide Deformylase.

ChemMedChem·2023
Same author

Praziquantel - 50 Years of Research.

ChemMedChem·2023
Same author

A Reinvestigation of the Role of the Sorbic Acid Tail on the Antibacterial and Anti-Tuberculosis Properties of Moiramide B.

ChemMedChem·2023

Area of Science:

  • Medicinal Chemistry
  • Parasitology
  • Structural Biology

Background:

  • The anthelmintic cyclooctadepsipeptide PF1022A is a potent drug against parasitic worms.
  • Understanding the role of its backbone is crucial for developing improved therapeutics.

Purpose of the Study:

  • To investigate the functional significance of the PF1022A backbone.
  • To synthesize and evaluate novel PF1022A analogues with modified backbones.
  • To explore structure-activity relationships for enhanced anthelmintic efficacy.

Main Methods:

  • Chemical synthesis of PF1022A analogues.
  • Incorporation of beta-turn mimetics, specifically (D)-Pro-(L)-Pro and BTD, into the cyclooctadepsipeptide structure.
  • Evaluation of anthelmintic activity of the synthesized compounds.

Related Experiment Videos

Main Results:

  • Successful synthesis of PF1022A analogues (compounds 12 and 14) featuring backbone modifications.
  • Compounds 12 and 14 demonstrated improved anthelmintic activity compared to the parent compound.
  • Preliminary structure-activity relationship analysis indicated that a symmetric conformation is associated with biological activity.

Conclusions:

  • Replacement of didepsipeptide units with beta-turn mimetics is a viable strategy for enhancing anthelmintic potency.
  • The findings provide insights into the structural requirements for PF1022A's biological activity.
  • Novel PF1022A analogues with improved efficacy were developed.